Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

IMPORTANCE: Most patients with atrial fibrillation (AF) and coronary artery disease have indications for preventing stroke with oral anticoagulation therapy and preventing myocardial infarction and stent thrombosis with platelet inhibition. OBJECTIVE: To evaluate whether the recently developed ABC (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Netw Open
Main Authors: Hijazi, Ziad, Oldgren, Jonas, Lindbäck, Johan, Alexander, John H., Alings, Marco, De Caterina, Raffaele, Eikelboom, John W., Ezekowitz, Michael D., Held, Claes, Huber, Kurt, Hylek, Elaine M., Granger, Christopher B., Lopes, Renato D., Vinereanu, Dragos, Siegbahn, Agneta, Wallentin, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495236/
https://ncbi.nlm.nih.gov/pubmed/32936298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.15943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados